miR-211 inhibits proliferation, invasion and migration of cervical cancer via targeting SPARC

Qu,Xuqin; Gao,Dezhen; Ren,Qingxia; Jiang,Xiufang; Bai,Jianhua; Sheng,Li

doi:10.3892/ol.2018.8735

miR-211 inhibits proliferation, invasion and migration of cervical cancer via targeting SPARC

Authors:
- Xuqin Qu
- Dezhen Gao
- Qingxia Ren
- Xiufang Jiang
- Jianhua Bai
- Li Sheng
View Affiliations

Affiliations: Reproductive Center, Yantaishan Hospital, Yantai, Shandong 264001, P.R. China, Department of Blood Transfusion, Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China, Clinical Laboratory, People's Hospital of Rizhao, Rizhao, Shandong 276826, P.R. China, Department of Obstetrics, People's Hospital of Zhangqiu District, Jinan, Shandong 250200, P.R. China, Clinical Laboratory, Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China
Published online on: May 17, 2018 https://doi.org/10.3892/ol.2018.8735
Pages: 853-860

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cervical cancer remains one of the most frequent gynecological malignancies among females around the world. Therefore, fully understanding the molecular mechanisms underlying the progression of cervical cancer may be critical for the development of effective therapeutic strategies against cervical cancer. The object was to evaluate the potential effect of miR-211 and verify its influence on the function of secreted protein acidic and rich in cysteine (SPARC) in cervical cancer. It was demonstrated that miR-211 was downregulated in cervical cancer cell lines (HeLa and C33A) and cervical cancer specimens, while SPARC expression level was higher in tumor tissues. We also revealed miR-211 upregulated expression could inhibit cells proliferation, migration and invasion in vivo. SPARC was confirmed as a direct and functional target of miR-211 and the inverse relationship between them was also observed. The results of the present study suggest that miR-211 reduced cancer growth, migration and invasion, and suppresses the SPARC expression in cervical cancer. This newly identified miR-211 may provide further insight into the progression and offers a promising target for cervical cancer therapy.

View Figures

View References

1	Pimple S, Mishra G and Shastri S: Global strategies for cervical cancer prevention. Curr Opin Obstet Gynecol. 28:4–10. 2016. View Article : Google Scholar : PubMed/NCBI
2	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
3	Sun Y, Yang X, Liu M and Tang H: B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells. Cancer Lett. 375:284–292. 2016. View Article : Google Scholar : PubMed/NCBI
4	Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B, et al: Landscape of genomic alterations in cervical carcinomas. Nature. 506:371–375. 2014. View Article : Google Scholar : PubMed/NCBI
5	Ambros V and Lee RC: Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol Biol. 265:131–158. 2004.PubMed/NCBI
6	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
7	Saumet A and Lecellier CH: microRNAs and personalized medicine: Evaluating their potential as cancer biomarkers. Adv Exp Med Biol. 888:5–15. 2015. View Article : Google Scholar : PubMed/NCBI
8	Srivastava SK, Arora S, Averett C, Singh S and Singh AP: Modulation of microRNAs by phytochemicals in cancer: Underlying mechanisms and translational significance. BioMed Res Int. 2015:8487102015. View Article : Google Scholar : PubMed/NCBI
9	Virant-Klun I, Ståhlberg A, Kubista M and Skutella T: MicroRNAs: From female fertility, germ cells, and stem cells to cancer in humans. Stem Cells Int. 2016:39849372016. View Article : Google Scholar : PubMed/NCBI
10	Ventura A and Jacks T: MicroRNAs and cancer: Short RNAs go a long way. Cell. 136:586–591. 2009. View Article : Google Scholar : PubMed/NCBI
11	Mazar J, Qi F, Lee B, Marchica J, Govindarajan S, Shelley J, Li JL, Ray A and Perera RJ: MicroRNA 211 functions as a metabolic switch in human melanoma cells. Mol Cell Biol. 36:1090–1108. 2016. View Article : Google Scholar : PubMed/NCBI
12	Deng B, Qu L, Li J, Fang J, Yang S, Cao Z, Mei Z and Sun X: MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma. Sci Rep. 6:266792016. View Article : Google Scholar : PubMed/NCBI
13	Zhang J, Lv J, Zhang F, Che H, Liao Q, Huang W, Li S and Li Y: MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma. J Neurooncol. 133:553–559. 2017. View Article : Google Scholar : PubMed/NCBI
14	Xia B, Yang S, Liu T and Lou G: miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6. Mol Cancer. 14:572015. View Article : Google Scholar : PubMed/NCBI
15	Ye L, Wang H and Liu B: miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1. Tumour Biol. 37:1151–1157. 2016. View Article : Google Scholar : PubMed/NCBI
16	Sümbül AT, Göğebakan B, Bayram S, Batmacı CY and Öztuzcu S: MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: A case-control study. Tumour Biol. 36:9703–9709. 2015. View Article : Google Scholar : PubMed/NCBI
17	Xu D, Liu S, Zhang L and Song L: MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4. Biochem Biophys Res Commun. 485:556–562. 2017. View Article : Google Scholar : PubMed/NCBI
18	Bornstein P and Sage EH: Matricellular proteins: Extracellular modulators of cell function. Curr Opin Cell Biol. 14:608–616. 2002. View Article : Google Scholar : PubMed/NCBI
19	Chen J, Shi D, Liu X, Fang S, Zhang J and Zhao Y: Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis. BMC Cancer. 12:4642012. View Article : Google Scholar : PubMed/NCBI
20	Zhao ZS, Wang YY, Chu YQ, Ye ZY and Tao HQ: SPARC is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res. 16:260–268. 2010.https://doi.org/10.1158/1078-0432.CCR-09-1247 View Article : Google Scholar : PubMed/NCBI
21	Derosa CA, Furusato B, Shaheduzzaman S, Srikantan V, Wang Z, Chen Y, Seifert M, Ravindranath L, Young D, Nau M, et al: Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression. Prostate Cancer Prostatic Dis. 15:150–156. 2012. View Article : Google Scholar : PubMed/NCBI
22	Shi Q, Bao S, Maxwell JA, Reese ED, Friedman HS, Bigner DD, Wang XF and Rich JN: Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation. J Biol Chem. 279:52200–52209. 2004. View Article : Google Scholar : PubMed/NCBI
23	Shi D, Jiang K, Fu Y, Fang R, Liu XI and Chen J: Overexpression of SPARC correlates with poor prognosis in patients with cervical carcinoma and regulates cancer cell epithelial-mesenchymal transition. Oncol Lett. 11:3251–3258. 2016. View Article : Google Scholar : PubMed/NCBI
24	Wang CY, Hua L, Sun J, Yao KH, Chen JT, Zhang JJ and Hu JH: MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4. Int J Clin Exp Pathol. 8:14013–14020. 2015.PubMed/NCBI
25	Wang L, Shen YF, Shi ZM, Shang XJ, Jin DL and Xi F: Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thyroid tumor cells by downregulating SOX11. J Clin Lab Anal e22293. 2017.
26	Manikandan J, Aarthi JJ, Kumar SD and Pushparaj PN: Oncomirs: The potential role of non-coding microRNAs in understanding cancer. Bioinformation. 2:330–334. 2008. View Article : Google Scholar : PubMed/NCBI
27	An XJ, Li YQ, Qu XY, Zhang J, Zhang LY, Wang M, Zhu L, Chen SY, Chen HX, Tu YT, et al: Silencing endothelin-3 expression attenuates the malignant behaviors of human melanoma cells by regulating SPARC levels. J Huazhong Univ Sci Technolog Med Sci. 33:581–586. 2013.https://doi.org/10.1007/s11596-013-1162-3 View Article : Google Scholar : PubMed/NCBI
28	Lin ZY and Chuang WL: Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells. Biomed Pharmacother. 66:454–458. 2012. View Article : Google Scholar : PubMed/NCBI